Insights into the epigenetic regulation of RNA-methylation on the development of colorectal cancer

Colorectal cancer (CRC) is a common malignancy of the gastrointestinal tract, the etiology of which has been linked to the complex interplay among genetic, environmental, and lifestyle factors.Despite substantial advances in diagnostic modalities and therapeutic strategies, CRC treatment remains challenging because of high rates of recurrence and metastasis, which contribute to an unfavorable prognosis, underscoring the critical need for robust biomarkers for early diagnosis and novel, mechanistically supported therapeutic targets.RNA methylation, a pivotal posttranscriptional regulatory mechanism, regulates diverse aspects of RNA metabolism, including splicing, translation, subcellular trafficking, and stability.Several chemically distinct subtypes of RNA methylation, including N6methyladenosine (m6A), 5-methylcytosine (m5C), N7-methylguanosine (m7G), and N1methyladenosine (m1A), have been implicated in CRC initiation, progression, and therapeutic resistance.In this review, we comprehensively summarize the current evidence on the subtype-specific regulatory roles of RNA methylation in CRC pathogenesis.We specifically delineate how distinct types of RNA methylation contribute to three interconnected oncogenic processes: glycolytic reprogramming, ferroptosis evasion, and tumor microenvironment remodeling.Furthermore, we integrate findings from RNA sequencing-based and epitranscriptomic studies to elucidate the downstream effectors and molecular mechanisms regulated by RNA methylation writers, erasers, and readers, highlighting translational opportunities for clinical biomarker development and targeted intervention.Collectively, this review provides a mechanistic framework to inform basic research, accelerate the identification of clinically actionable diagnostic and prognostic markers, and advance RNA methylation-directed therapeutic strategies for CRC.

Authors

Institutions

Publication Details

Journal
Journal of Bio-X Research
Published
2026-11-18
DOI
https://doi.org/10.34133/jbioxresearch.0095
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Insights into the epigenetic regulation of RNA-methylation on the development of colorectal cancer

Yutong Jin, Shuai Zhang, Wangjie Sun, Yuhui Wang et al.
Journal of Bio-X Research
RNA modifications and cancer
article

Insights into the epigenetic regulation of RNA-methylation on the development of colorectal cancer

Yutong Jin, Shuai Zhang, Wangjie Sun, Yuhui Wang, Yuexuan Shi, Mai Li, Xiangling Wang, Zheyu Li
article en

Abstract

Colorectal cancer (CRC) is a common malignancy of the gastrointestinal tract, the etiology of which has been linked to the complex interplay among genetic, environmental, and lifestyle factors.Despite substantial advances in diagnostic modalities and therapeutic strategies, CRC treatment remains challenging because of high rates of recurrence and metastasis, which contribute to an unfavorable prognosis, underscoring the critical need for robust biomarkers for early diagnosis and novel, mechanistically supported therapeutic targets.RNA methylation, a pivotal posttranscriptional regulatory mechanism, regulates diverse aspects of RNA metabolism, including splicing, translation, subcellular trafficking, and stability.Several chemically distinct subtypes of RNA methylation, including N6methyladenosine (m6A), 5-methylcytosine (m5C), N7-methylguanosine (m7G), and N1methyladenosine (m1A), have been implicated in CRC initiation, progression, and therapeutic resistance.In this review, we comprehensively summarize the current evidence on the subtype-specific regulatory roles of RNA methylation in CRC pathogenesis.We specifically delineate how distinct types of RNA methylation contribute to three interconnected oncogenic processes: glycolytic reprogramming, ferroptosis evasion, and tumor microenvironment remodeling.Furthermore, we integrate findings from RNA sequencing-based and epitranscriptomic studies to elucidate the downstream effectors and molecular mechanisms regulated by RNA methylation writers, erasers, and readers, highlighting translational opportunities for clinical biomarker development and targeted intervention.Collectively, this review provides a mechanistic framework to inform basic research, accelerate the identification of clinically actionable diagnostic and prognostic markers, and advance RNA methylation-directed therapeutic strategies for CRC.

Journal of Bio-X Research
Tianjin University of Traditional Chinese Medicine (CN)
National Natural Science Foundation of China, Natural Science Foundation of Tianjin City
Good health and well-being
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon